Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.
Press releases published on August 12, 2025
Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update
GlobeNewswire
·
August 12, 2025
PIVOT-PO Phase 3 trial evaluating tebipenem Hbr in complicated urinary tract infection (cUTI) patients stopped early for efficacy following review by independent data monitoring committee (IDMC) Spero, along with its development partner, GSK, plans to …
Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 12, 2025
– Positive ENLIGHTEN 2 Phase 3 results announced in June 2025 propel business activities in manufacturing, regulatory strategy and ENLIGHTEN clinical dataset analysis to advance path forward for LYR-210 for treatment of chronic rhinosinusitis (CRS) – – …
Compass Therapeutics Announces Proposed Public Offering
GlobeNewswire
·
August 12, 2025
BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today …
ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
GlobeNewswire
·
August 12, 2025
FDA confirmed at a July 2025 Type B meeting and in the subsequent meeting minutes that eGFR slope is an acceptable surrogate endpoint for accelerated approval of rilparencel in patients with type 2 diabetes and advanced CKD; FDA also confirmed that the …
Pathway Health Recognized as a 2025 Minnesota Star Tribune National Standard Top Workplace for the Third Consecutive Year
GlobeNewswire
·
August 12, 2025
LAKE ELMO, Minn., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Pathway Health, a leading provider of health care consulting services, interim and permanent leadership, technology implementation, and training solutions, has been recognized as a 2025 Minnesota Star …
Cognition Therapeutics Receives End-of-Phase 2 Meeting Minutes Confirming Alignment with U.S. FDA on Registrational Path for Zervimesine (CT1812) in Alzheimer’s Disease
GlobeNewswire
·
August 12, 2025
- Cognition and FDA align on enriched population, study design, and endpoints - PURCHASE, N.Y., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat …
Spectral Medical and Vantive Announce Topline Results from Spectral’s Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock
GlobeNewswire
·
August 12, 2025
Results exceed prespecified primary endpoint of 95% posterior probability of benefit for PMX on 28-day mortality Pooled absolute risk reduction of 8.3%; Relative risk reduction of 18% Key secondary endpoint: 90-day Mortality 17.4% lower with PMX and >99% …
Spectral AI Announces 2025 Second Quarter Financial Results
GlobeNewswire
·
August 12, 2025
Q2 Overview Research …
Ocugen, Inc. Announces Closing of $20 Million Registered Direct Offering of Common Stock and Warrants
GlobeNewswire
·
August 12, 2025
MALVERN, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the closing of its previously announced registered direct …
CORRECTION - HealthEquity Community Foundation Expands National Impact with $50,000 in Grants
GlobeNewswire
·
August 12, 2025
DRAPER, Utah, Aug. 12, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by HealthEquity, Inc., please note that the list of organizations that received funding in the summer 2025 grant cycle has been updated. The corrected …
AlayaCare selected to modernize 33 community support agencies, powering the next phase of digital transformation in community care
GlobeNewswire
·
August 12, 2025
TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- AlayaCare, a leading provider of cloud-based home and community care solutions, is proud to announce it has been selected as the vendor of record in a collaborative RFP process for 33 Community Support Service ( …
AlayaCare, sélectionnée pour moderniser 33 agences de soutien communautaire, propulsant ainsi la prochaine phase de transformation numérique dans les soins communautaires
GlobeNewswire
·
August 12, 2025
TORONTO, 12 août 2025 (GLOBE NEWSWIRE) -- AlayaCare, chef de file des solutions infonuagiques pour les soins à domicile et les soins communautaires, est fière d’annoncer qu’elle a été sélectionnée comme fournisseur attitré à l’issue d’un processus d’appel …
SRx Health Solutions Obtains Initial Order under CCAA for its Canadian Subsidiary
GlobeNewswire
·
August 12, 2025
TAMPA, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced that its subsidiary, SRx Health Solutions (Canada), Inc.(“SRx Canada”) and …
Mrs. Ohio American Joins Wigal & Kluemper Orthodontics to Promote Lifelong Smile Health
EIN Presswire
·
August 12, 2025
Wigal …
MedTech Manufacturer Juvent Joins the Inc. 5000 List of America’s Fastest-Growing Private Companies
GlobeNewswire
·
August 12, 2025
CHATTANOOGA, Tenn., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced that Juvent, makers of the Juvent Micro-Impact Platform, is in the top 15% of …
Erectile Dysfunction Devices Market Set to Surge at a CAGR of ~8% by 2032 with Rising Global Demand and Technological Advancements | DelveInsight
GlobeNewswire
·
August 12, 2025
New York, USA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Erectile Dysfunction Devices Market Set to Surge at a CAGR of ~8% by 2032 with Rising Global Demand and Technological Advancements | DelveInsight The demand for erectile dysfunction devices is largely fueled …
Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
GlobeNewswire
·
August 12, 2025
New York, USA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight Cannabinoids are specific chemical compounds found in cannabis, such as …
Birches Health, a leading clinical provider of Gambling Addiction care, expands statewide access to specialized Problem Gambling treatment across Nevada
GlobeNewswire
·
August 12, 2025
LAS VEGAS, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Using funding from the Nevada Division of Public and Behavioral Health (DPBH), Birches Health today launched a groundbreaking program focused on expanding access to evidence-based specialized problem gambling …
CORRECTION: Kaléo Receives Inaugural Medical CBRN Defense Consortium Innovation Award for Prototype Development of its Rapid Opioid Countermeasure System (Naloxone HCl Injection, USP) Antidote
GlobeNewswire
·
August 12, 2025
Richmond, Virginia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injector innovation, today announced it received the Prototype Innovation award by the Medical CBRN Defense Consortium (MCDC) in …
Compass Health announces completion of first-ever capital campaign to fund state-of-the-art facility for intensive behavioral health services
GlobeNewswire
·
August 12, 2025
EVERETT, Wash., Aug. 12, 2025 (GLOBE NEWSWIRE) -- When Compass Health set out to build a state-of-the-art facility to meet Northwest Washington’s growing need for intensive behavioral health services, it knew the project would require broad community …